386 related articles for article (PubMed ID: 31727097)
1. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
[TBL] [Abstract][Full Text] [Related]
2. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
3. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Kowarik MC; Cepok S; Sellner J; Grummel V; Weber MS; Korn T; Berthele A; Hemmer B
J Neuroinflammation; 2012 May; 9():93. PubMed ID: 22591862
[TBL] [Abstract][Full Text] [Related]
4. CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls.
Vrethem M; Dahle C; Ekerfelt C; Forsberg P; Danielsson O; Ernerudh J
Acta Neurol Scand; 1998 Apr; 97(4):215-20. PubMed ID: 9576634
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis.
Rodríguez-Martín E; Picón C; Costa-Frossard L; Alenda R; Sainz de la Maza S; Roldán E; Espiño M; Villar LM; Álvarez-Cermeño JC
Clin Exp Immunol; 2015 May; 180(2):243-9. PubMed ID: 25565222
[TBL] [Abstract][Full Text] [Related]
6. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.
Heming M; Schulte-Mecklenbeck A; Brix T; Wolbert J; Ruland T; Klotz L; Meuth SG; Gross CC; Wiendl H; Meyer Zu Hörste G
Front Immunol; 2019; 10():515. PubMed ID: 30984164
[No Abstract] [Full Text] [Related]
7. Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.
Nemecek A; Zimmermann H; Rübenthaler J; Fleischer V; Paterka M; Luessi F; Müller-Forell W; Zipp F; Siffrin V
Mult Scler; 2016 Apr; 22(4):483-93. PubMed ID: 26163073
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.
Karnell FG; Lin D; Motley S; Duhen T; Lim N; Campbell DJ; Turka LA; Maecker HT; Harris KM
Clin Exp Immunol; 2017 Sep; 189(3):268-278. PubMed ID: 28498568
[TBL] [Abstract][Full Text] [Related]
9. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
Maimone D; Gregory S; Arnason BG; Reder AT
J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
[TBL] [Abstract][Full Text] [Related]
10. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
[TBL] [Abstract][Full Text] [Related]
11. Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases.
Kowarik MC; Grummel V; Wemlinger S; Buck D; Weber MS; Berthele A; Hemmer B
J Neurol; 2014 Jan; 261(1):130-43. PubMed ID: 24162037
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid cytokines in Lyme neuroborreliosis.
Pietikäinen A; Maksimow M; Kauko T; Hurme S; Salmi M; Hytönen J
J Neuroinflammation; 2016 Oct; 13(1):273. PubMed ID: 27756335
[TBL] [Abstract][Full Text] [Related]
13. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
[TBL] [Abstract][Full Text] [Related]
14. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.
Farina G; Magliozzi R; Pitteri M; Reynolds R; Rossi S; Gajofatto A; Benedetti MD; Facchiano F; Monaco S; Calabrese M
J Neuroinflammation; 2017 Feb; 14(1):40. PubMed ID: 28222766
[TBL] [Abstract][Full Text] [Related]
15. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Romme Christensen J; Börnsen L; Hesse D; Krakauer M; Sørensen PS; Søndergaard HB; Sellebjerg F
J Neuroinflammation; 2012 Sep; 9():215. PubMed ID: 22978757
[TBL] [Abstract][Full Text] [Related]
16. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients.
Scolozzi R; Boccafogli A; Tola MR; Vicentini L; Camerani A; Degani D; Granieri E; Caniatti L; Paolino E
J Neurol Sci; 1992 Mar; 108(1):93-8. PubMed ID: 1352538
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
Magliozzi R; Howell OW; Nicholas R; Cruciani C; Castellaro M; Romualdi C; Rossi S; Pitteri M; Benedetti MD; Gajofatto A; Pizzini FB; Montemezzi S; Rasia S; Capra R; Bertoldo A; Facchiano F; Monaco S; Reynolds R; Calabrese M
Ann Neurol; 2018 Apr; 83(4):739-755. PubMed ID: 29518260
[TBL] [Abstract][Full Text] [Related]
18. Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.
DiSano KD; Linzey MR; Royce DB; Pachner AR; Gilli F
J Neuroinflammation; 2019 May; 16(1):109. PubMed ID: 31118079
[TBL] [Abstract][Full Text] [Related]
19. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8.
Kleine TO; Zwerenz P; Graser C; Zöfel P
Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+ and the CD8+ subsets.
Wallström E; Khademi M; Andersson M; Olsson T
Eur J Neurol; 2000 Jan; 7(1):71-6. PubMed ID: 10809917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
